Telehealth effectiveness for pre‐exposure prophylaxis delivery in Brazilian public services: the Combine! Study

Author:

Grangeiro Alexandre1ORCID,Santos Lorruan Alves do1,Estevam Denize Lotufo2,Munhoz Rosemeire2,Arruda Érico3,de Moraes Renata Amaral3,de Quadros Winkler Lisiane4,Neves Lis Aparecida de Souza5,Santos Juliane Cardoso Villela6,Kruppa Mariele6,Zucchi Eliana Miura7,Escuder Maria Mercedes8,Leal Andréa Fachel9,Koyama Mitti Ayako Hara10,Peres Maria Fernanda Tourinho1,Couto Marcia Thereza1,Neto José Eluf1,

Affiliation:

1. Faculdade de Medicina Universidade de São Paulo São Paulo Brazil

2. Centro de Referência e Treinamento DST/Aids São Paulo Brazil

3. Hospital São José de Doenças Infecciosas Fortaleza Brazil

4. Serviço de Atenção Especializada do Centro de Saúde IAPI Porto Alegre Brazil

5. Prefeitura Municipal de Ribeirão Preto, Ribeirão Preto São Paulo Brazil

6. Centro de Orientação e Aconselhamento Curitiba Brazil

7. Programa de Pós‐Graduação em Saúde Coletiva Universidade Catolica de Santos Santos São Paulo Brazil

8. Instituto de Saúde Secretaria de Estado da Saúde de São Paulo São Paulo Brazil

9. Instituto de Filosofia e Ciências Humanas Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

10. Kamiyama Consultoria em Estatística Ltda São Paulo Brazil

Abstract

AbstractIntroductionPre‐exposure prophylaxis (PrEP) delivery based on user needs can enhance PrEP access and impact. We examined whether telehealth for daily oral PrEP delivery could change the indicators of care related to prophylactic use in five Brazilian public HIV clinics (testing centres, outpatient clinics and infectious disease hospitals).MethodsBetween July 2019 and December 2020, clients on PrEP for at least 6 months could transition to telehealth or stay with in‐person follow‐up. Clients were clinically monitored until June 2021. A desktop or mobile application was developed, comprising three asynchronous consultations and one annual in‐person consultation visit. Predictors influencing telehealth preference and care outcomes were examined. The analysis encompassed intent‐to‐treat (first choice) and adjustments for sexual practices, schooling, age, duration of PrEP use and PrEP status during the choice period.ResultsOf 470 users, 52% chose telehealth, with the adjusted odds ratio (aOR) increasing over time for PrEP use (aOR for 25–months of use: 4.90; 95% CI: 1.32–18.25), having discontinued PrEP at the time of the choice (aOR: 2.91; 95% CI: 1.40–6.06) and having health insurance (aOR: 1.91; 95% CI: 1.24–2.94) and decreasing for those who reported higher‐risk behaviour (aOR for unprotected anal sex: 0.51; 95% CI: 0.29–0.88). After an average follow‐up period of 1.6 years (95% CI: 1.5–1.7), the risk of discontinuing PrEP (not having the medication for more than 90 days) was 34% lower with telehealth (adjusted hazard ratio: 0.66; 95% CI: 0.45–0.97). When adjusted by mixed linear regression, no differences in adherence (measured by mean medication possession rate) were found between in‐person and telehealth (p = 0.486) or at pre‐ and post‐telehealth follow‐ups (p = 0.245). Sexually transmitted infections increased between the pre‐follow‐up and post‐follow‐up choices and were not associated with in‐person or telehealth (p = 0.528). No HIV infections were observed.ConclusionsOur findings indicate that telehealth for PrEP delivery can enhance service rationalization and reinforce the prevention cascade. This approach reduces prophylaxis interruptions and is mainly preferred by individuals with lower demands for healthcare services.

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3